Pack Pharma India Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.24 Cr
- Satisfied Charges ₹ 2.94 Cr
- Revenue Growth %
- Profit Growth 8158.88%
- Ebitda 26860.60%
- Net Worth 828.75%
- Total Assets 2940.36%
About Pack Pharma India
Pack Pharma India Private Limited (PPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 December 2021 (Three years and one month 13 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹4.24 Cr. The company has closed loans amounting to ₹2.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mannu Sahni and Sanya Sahni serve as directors at the Company.
Company Details
-
Location
Panchkula, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290HR2021PTC100022
-
Company No.
100022
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Dec 2021
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Pack Pharma India?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mannu Sahni | Director | 21-Dec-2021 | Current |
Sanya Sahni | Director | 21-Dec-2021 | Current |
Financial Performance of Pack Pharma India.
Pack Pharma India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 8158.88% increase in profit. The company's net worth Soared by an impressive increase of 828.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Pack Pharma India?
Unlock access to Pack Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹42.35 M
₹29.40 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.24 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 May 2024 | Hdfc Bank Limited | ₹3.95 Cr | Open |
07 Dec 2023 | Hdfc Bank Limited | ₹2.84 M | Open |
29 May 2023 | Others | ₹2.94 Cr | Satisfied |
How Many Employees Work at Pack Pharma India?
Unlock and access historical data on people associated with Pack Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pack Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pack Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.